vs
Side-by-side financial comparison of CARTERS INC (CRI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $757.8M, roughly 2.0× CARTERS INC). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 1.5%, a 2.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -0.1%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-144.1M).
Carter's, Inc. is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CRI vs ONC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $757.8M | $1.5B |
| Net Profit | $11.6M | $66.5M |
| Gross Margin | 45.1% | 90.5% |
| Operating Margin | 3.8% | 12.4% |
| Net Margin | 1.5% | 4.4% |
| Revenue YoY | -0.1% | 32.8% |
| Net Profit YoY | -80.1% | 143.8% |
| EPS (diluted) | $0.32 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.5B | ||
| Q3 25 | $757.8M | $1.4B | ||
| Q2 25 | $585.3M | $1.3B | ||
| Q1 25 | $629.8M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $929.2M | ||
| Q1 24 | — | $751.7M |
| Q4 25 | — | $66.5M | ||
| Q3 25 | $11.6M | $124.8M | ||
| Q2 25 | $446.0K | $94.3M | ||
| Q1 25 | $15.5M | $1.3M | ||
| Q4 24 | — | $-151.9M | ||
| Q3 24 | — | $-121.3M | ||
| Q2 24 | — | $-120.4M | ||
| Q1 24 | — | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | 45.1% | 86.1% | ||
| Q2 25 | 48.1% | 87.5% | ||
| Q1 25 | 46.2% | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | — | 12.4% | ||
| Q3 25 | 3.8% | 11.5% | ||
| Q2 25 | 0.7% | 6.7% | ||
| Q1 25 | 4.1% | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | — | -12.0% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -34.8% |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 1.5% | 8.8% | ||
| Q2 25 | 0.1% | 7.2% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | — | -12.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | — | -33.4% |
| Q4 25 | — | $0.05 | ||
| Q3 25 | $0.32 | $0.08 | ||
| Q2 25 | $0.01 | $0.06 | ||
| Q1 25 | $0.43 | $0.00 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | — | $-0.09 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.2M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $864.6M | $4.4B |
| Total Assets | $2.5B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | $184.2M | $4.0B | ||
| Q2 25 | $338.2M | $2.8B | ||
| Q1 25 | $320.8M | $2.5B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $4.4B | ||
| Q3 25 | $864.6M | $4.1B | ||
| Q2 25 | $853.9M | $3.8B | ||
| Q1 25 | $847.2M | $3.5B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | — | $3.4B |
| Q4 25 | — | $8.2B | ||
| Q3 25 | $2.5B | $7.6B | ||
| Q2 25 | $2.5B | $6.3B | ||
| Q1 25 | $2.3B | $5.8B | ||
| Q4 24 | — | $5.9B | ||
| Q3 24 | — | $5.8B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | — | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-128.0M | $417.3M |
| Free Cash FlowOCF − Capex | $-144.1M | $379.8M |
| FCF MarginFCF / Revenue | -19.0% | 25.4% |
| Capex IntensityCapex / Revenue | 2.1% | 2.5% |
| Cash ConversionOCF / Net Profit | -11.04× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $417.3M | ||
| Q3 25 | $-128.0M | $402.6M | ||
| Q2 25 | $40.3M | $263.6M | ||
| Q1 25 | $-48.6M | $44.1M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | — | $188.4M | ||
| Q2 24 | — | $-95.6M | ||
| Q1 24 | — | $-308.6M |
| Q4 25 | — | $379.8M | ||
| Q3 25 | $-144.1M | $354.5M | ||
| Q2 25 | $24.1M | $219.8M | ||
| Q1 25 | $-59.0M | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M | ||
| Q1 24 | — | $-465.1M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | -19.0% | 25.1% | ||
| Q2 25 | 4.1% | 16.7% | ||
| Q1 25 | -9.4% | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | — | -61.9% |
| Q4 25 | — | 2.5% | ||
| Q3 25 | 2.1% | 3.4% | ||
| Q2 25 | 2.8% | 3.3% | ||
| Q1 25 | 1.6% | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | -11.04× | 3.22× | ||
| Q2 25 | 90.37× | 2.79× | ||
| Q1 25 | -3.13× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
ONC
Segment breakdown not available.
